FindTrial
Sign In

The longitudinal change of circulating tumor cell during chemotherapy and its correlation with disease features, treatment response and survival profile of advanced gallbladder carcinoma

The longitudinal change of circulating tumor cell during chemotherapy and its correlation with disease features, treatment response and survival profile of advanced gallbladder carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052172
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gallbladder carcinoma

Interventions

Case series:No

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with gallbladder cancer; 2. Unresectable gallbladder cancer; 3. The age is greater than or equal to 18 years old; 4. ECOG PS score 0-1 points; 5. The function of liver, kidney and bone marrow is normal, suitable for chemotherapy; 6. The lesions can be assessed under CT or MRI.

Exclusion criteria

Exclusion criteria: 1.????? 2.?????????? 3.????????

Design outcomes

Primary

MeasureTime frame
Progression-free survival;—

Secondary

MeasureTime frame
overall survival;Treatment response;—

Countries

China

Contacts

Public ContactLinshi Wu

Renji Hospital, School of Medicine, Shanghai Jiaotong University

wulinshirenji@163.com+86 13651810232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026